Home Newsfeeds Vuzix Smart Glasses Supporting Deutsche Telekom’s Enhanced Telephony For Connected Workers At Digital X 2022

News

Vuzix Smart Glasses Supporting Deutsche Telekom’s Enhanced Telephony For Connected Workers At Digital X 2022

Vuzix invited to highlight new Zoom X conferencing service at event

byBenzinga Newsdesk

September 9, 2022

1 minute read

Vuzix invited to highlight new Zoom X conferencing service at event

Wells Fargo Maintains Equal-Weight on Eaton Corp, Raises Price Target to $163

By Benzinga Newsdesk

January 5, 10:39 AM

Wells Fargo analyst Joe O'Dea maintains Eaton Corp (NYSE:ETN) with a Equal-Weight and raises the price target from $157 to $163.

ETN

Alzheimer’s Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer’s Treatments

By Vandana Singh

March 16, 12:00 PM

The Alzheimer’s Association has launched a grassroots lobbying campaign while deploying 1,000 people, either patients or caring for someone with…

BIIB

Price Over Earnings Overview: Capital One Finl

By Benzinga Insights

November 28, 12:00 PM

In the current session, the stock is trading at $107.49, after a 1.24% spike. Over the past month,…

COF

Intercept Announces New Findings From Long-term Extension Of Landmark POISE Trial In PBC Showing Importance Of Biomarkers Beyond ALP At AASLD The Liver Meeting 2023

By Benzinga Newsdesk

November 10, 9:02 AM

New analysis demonstrates the impact of OCA on achievement of GGT <3.2×ULN and ALP <1.5×ULNFindings suggest that OCA has the potential to reduce the liver biomarker GGT, in addition to well-known effects

Vuzix Smart Glasses Supporting Deutsche Telekom’s Enhanced Telephony For Connected Workers At Digital X 2022

Related Posts

Wells Fargo Maintains Equal-Weight on Eaton Corp, Raises Price Target to $163

Alzheimer’s Association Launches Grassroots Level Lobbying For Medicare Coverage Of Alzheimer’s Treatments

Price Over Earnings Overview: Capital One Finl

Intercept Announces New Findings From Long-term Extension Of Landmark POISE Trial In PBC Showing Importance Of Biomarkers Beyond ALP At AASLD The Liver Meeting 2023